This chapter outlines the committee's efforts to review the basis for available evidence of whether marijuana or cannabinoids may be present in pre-existing health conditions.

Health conditions reviewed

In this chapter include chronic pain, cancer, nausea and vomiting caused by chemicals, anorexia and weight loss associated with HIV, irritable bowel syndrome, epilepsy, constipation, Tourette syndrome, amyotrophic lateral sclerosis, Huntington's disease, , dystonia. , dementia, glaucoma, traumatic brain injury, addiction, anxiety, depression, sleep disturbances, post-traumatic stress disorder, and epilepsy and other mental disorders.

The committee has made several research conclusions related to these health conclusions; however, it is important that the Cannabis edible of the chapter are translated within the context of the limitations discussed in the Finding Discussion sections above.

• See Box 4-1
• For a summary of
• Chapter chapters

We have found compelling or tangible evidence (ranging from a moderate to moderate effect) to the benefit of marijuana or cannabinoids for chronic pain, nausea and vomiting caused by chemicals, and patient-reported symptoms of spasticity associated with multiple sclerosis.

With chemically

Induced nausea and vomiting and spasticity associated with multiple sclerosis, the main route of administration tested was oral administration. For chronic pain, many studies examined oral marijuana extract, although some examined smoked or smoked marijuana. It is unknown at this time what he will do after leaving the post.

In most of the

Cases mentioned above, there is insufficient or no evidence to draw conclusions about treatment outcomes. The potential use of cannabinoids in many of these conditions, such as epilepsy and post-traumatic stress disorder, should be prioritized, Cannabis gummies the large number of people who use marijuana in those conditions (Cougle et al., 2011; Massot-Tarrús and McLachlan, 2016).

• As shown in the section on
• Discussion Discovery chapter, there
• Are common themes in the
• Type of research limitations
• Found in this evidence base

The most common limitations are in research design (e.g., lack of appropriate control groups, lack of long-term follow-up), small sample sizes, and research spaces in evaluating potential therapeutic benefits of different types of cannabis (e.g., marijuana plant).

These limitations highlight the need for more in-depth research to provide comprehensive and Weed gummies evidence on the therapeutic effects of cannabis and cannabinoids.

There are few studies

That can evoke strong emotions among physicians, scientists, researchers, policymakers, and the public rather than medical marijuana. Is it safe? Should it be legal? Forbidden crime? Has its effectiveness been proven?

In what circumstances is it useful? Is it addictive? How do we keep it out of the hands of young people? Is it really the "amazing drug" that people call it? Is marijuana treatment a strategy for approving general marijuana?

These are some of the best questions about this topic, questions that I will definitely avoid to Thc gummies on two specific areas: why do patients find it helpful, and how can they talk to their doctor?